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ABSTRACT
MicroRNAs (miRNAs) are critical for both development
and function of the central nervous system. Signiﬁcant
evidence suggests that abnormal expression of miRNAs
is associated with neurodevelopmental disorders.
MeCP2 protein is an epigenetic regulator repressing or
activating gene transcription by binding to methylated
DNA. Both loss-of-function and gain-of-function muta-
tions in the MECP2 gene lead to neurodevelopmental
disorders such as Rett syndrome, autism and MECP2
duplication syndrome. In this study, we demonstrate
that miR-130a inhibits neurite outgrowth and reduces
dendritic spine density as well as dendritic complexity.
Bioinformatics analyses, cell cultures and biochemical
experiments indicate that miR-130a targets MECP2 and
down-regulates MeCP2 protein expression. Further-
more, expression of the wild-type MeCP2, but not a loss-
of-function mutant, rescues the miR-130a-induced phe-
notype. Our study uncovers the MECP2 gene as a pre-
vious unknown target for miR-130a, supporting that
miR-130a may play a role in neurodevelopment by reg-
ulating MeCP2. Together with data from other groups,
our work suggests that a feedback regulatory mecha-
nism involving both miR-130a and MeCP2 may serve to
ensure their appropriate expression and function in
neural development.
KEYWORDS miR-130a, MECP2, neurite outgrowth,
dendritic spines, dendrite morphology
INTRODUCTION
MicroRNAs (miRNAs) are small non-coding RNAs of 16–28
nucleotides (nt) in lengths. They are transcribed into pri-
miRNA, which are then cleaved by Drosha to form pre-
miRNA in the nucleus. After being transported to the cyto-
plasm and then cleaved by Dicer, mature miRNAs incorpo-
rate with AGO proteins to form RNA-induced silencing
complexes (RISCs) to silence target mRNAs (Finnegan and
Pasquinelli, 2013). MicroRNAs play important roles in the
formation and the function of the nervous system (McNeill
and Van Vactor, 2012). Aberrant expression of miRNAs may
lead to neurodevelopmental and neurodegenerative dis-
eases (Im and Kenny, 2012). We identiﬁed microRNA-130a
(miR-130a) in a search for microRNAs regulated by the Tar-
DNA binding protein-43 (TDP-43) (The detail will be descri-
bed in a separate paper). It has been reported that miR-130a
regulates neurogenesis by inhibiting the synthesis of sub-
stance P (Greco and Rameshwar, 2007), a neuropeptide
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that can increase neurite outgrowth of cultured chick dorsal
root ganglia (Shigehiko and Takeshi, 1978). In Xenopus
laevis, miR-130a is expressed in anterior neural tissues,
eyes and branchial arches (Walker and Harland, 2008),
and down-regulation of miR-130a led to smaller eyes
(Gessert et al., 2010). In mice, miR-130a is expressed in
developing somites, neural tube and restricted regions of
the brain after embryonic day 9.5 (Hoesel et al., 2010).
Cerebral expression of miR-130a then decreases during
the postnatal period throughout the rest of development
and is detected only at a low level in the adult mouse cortex
(Eda et al., 2011; Søe et al., 2011). Several studies suggest
that dysregulation of miR-130a may be associated with
neurodevelopmental disorders. For example, the expres-
sion of miR-130a is up-regulated in the serum of children
with autism (Vasu et al., 2014). Analyses of the copy
number variation (CNV) of miR-130a have led to the
identiﬁcation of 2 patients diagnosed with autism spectrum
disorder carrying duplications of the locus (11q12.1) con-
taining miR-130a (Rosenfeld et al., 2010). These reports
suggest a potential role for miR-130a in neural develop-
ment. However, the target genes and mechanisms by
which miR-130a functions in neurons remain to be
investigated.
MECP2 (Methyl-CpG-binding Protein 2) is an X-linked
gene, encoding a methylated DNA-binding protein and has
been identiﬁed as a causative gene in Rett syndrome (Amir
et al., 1999; Lewis et al., 1992; reviewed in Lombardi et al.,
2015). The MeCP2 protein has multiple biological functions,
including regulating RNA transcription, involving in RNA
splicing and miRNA biogenesis (Chahrour et al., 2008;
Cheng et al., 2014; Maunakea et al., 2013; Nan et al., 1998;
Young et al., 2005; Lombardi et al., 2015). Loss and gain of
function mutations of MeCP2 lead to Rett syndrome and
MECP2 duplication syndrome, both of which are progressive
neurological disorders characterized by intellectual disability,
autism and developmental regression (Lombardi et al.,
2015). Postmortem brain pathology analyses, MeCP2
mouse models and in vitro experiments suggest that MeCP2
regulates axon outgrowth, dendritic spine formation and
dendritic arbor complexity (Chao et al., 2007; Chapleau
et al., 2009; Cheng et al., 2014; Jiang et al., 2013; Jugloff
et al., 2005; Lombardi et al., 2015). Neuronal expression of
MeCP2 at an appropriate level is crucial for neural devel-
opment. However, the mechanisms by which how MeCP2 is
regulated remain to be elucidated.
The mammalian MECP2 gene has a highly conserved
long 3′ untranslated region (3′UTR) which contains multiple
binding sites for microRNAs (Coy et al., 1999; McGowan and
Pang, 2015). It was proposed that microRNAs binding to the
3′UTR of MECP2 and regulating its expression might con-
tribute to neuronal maturation and neurodevelopmental dis-
eases (Hansen et al., 2010). In the present study, we
examined the interaction between miR-130a and MeCP2.
Our data demonstrate that miR-130a inhibits neurite out-
growth and dendritic spine formation by regulating MeCP2.
RESULTS
MiR-130a is expressed in developing cerebral cortex
and is predicted to regulate neuronal function
The mature sequence of miR-130a is conserved across
various species including mammals, birds, amphibians and
ﬁsh (Fig. S1). To study the function of miR-130a in neu-
rodevelopment, we ﬁrst examined the expression of miR-
130a in developing rat brains. Primary and mature rno-miR-
130a were detected in the rat cerebral cortices at both
embryonic (E18) and postnatal (P1) stages (Fig. 1), which is
consistent with previous results in mice (Hoesel et al., 2010).
There were no dramatic changes of the level of miR-130a
between the late embryonic and early postnatal stages.
To begin to explore biological function of miR-130a, we
employed a bioinformatics approach using three miRNA tar-
get prediction tools—TargetScan, miRanda and PicTar—to
predict candidate target genes for miR-130a (Agarwal et al.,
2015; Krek et al., 2005; Betel et al., 2008). The pathway
enrichment analysis (KOBAS 2.0; Xie et al., 2011) revealed
potential target genes involved in multiple pathways important
for neuronal function, such as axon guidance, synaptic vesicle
formation and axonal transport. A number of the predicted
miR-130a target genes are also associated with neurodevel-
opmental disorders, such as autism, schizophrenia and
hereditary spastic paraplegia (Table 1). These results, toge-
ther with its expression in brain tissues, suggest that miR-
130a may play an important role in regulating expression of
genes crucial for the function of the nervous system.
MiR-130a inhibits neurite outgrowth
Neuronal differentiation is an early and fundamental event in
neurodevelopment. The sprouting and outgrowth of neurites
E18 P1





Figure 1. Expression of miR-130a in embryonic and
postnatal rat brains. Rat cortical neurons were harvested
from brains at the stages of E18 and P1. The levels of
mature miR-130a (with U6 as an internal control) (upper
panel) and primary miR-130a (with GAPDH as an internal
control) (lower panel) were detected by RT-PCR. The last
lane in each panel contained the negative control (NC) in
which reverse transcriptase was omitted from the cDNA
synthesis reactions.
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followed by the formation of axons and dendrites is an initial
critical process in the early stage of development of the
nervous system (Lefebvre, Sanes and Kay, 2015; Takano
et al., 2015 and references within). To investigate the role of
miR-130a in neuronal development, we examined the effect
of miR-130a on neurite outgrowth using primary rat neuronal
cultures. Cortical neurons were transfected with a control
vector or a plasmid expressing pri-miR-130a that also
expressed GFP to mark transfected neurons. Seventy-two
hours following transfection, the neurite length was mea-
sured by tracing the longest neurite of randomly-selected
transfected neurons and quantiﬁed using Image J, as pub-
lished previously (Gao et al., 2010 and reference within).
Neurons transfected with miR-130a showed shorter neurite
length, approximately 65% of that in the control neurons
(Fig. 2A and 2C). To conﬁrm the effect of miR-130a on
neurite outgrowth, a speciﬁc RNA inhibitor for miR-130a was
used. Rat primary cortical neurons were transfected with a
scrambled RNA control or the miR-130a inhibitor together
with a plasmid expressing GFP. Neurons transfected with the
miR-130a inhibitor showed greater neurite length, approxi-
mately 150% of that in neurons transfected with the control
scrambled RNA (Fig. 2B and 2C). This effect of miR-130a on
the neurite length was not due to its effect on neuronal
survival, because miR-130a did not affect neuronal death as
shown by a Terminal deoxyribonucleotidyl transferase-me-
diated dUTP-digoxigenin nick end labeling (TUNEL) assay
and nuclear staining (Fig. S2). We also examined whether
miR-130 affected the number of neurite branches per neuron
(Fig. S3A). Quantitative analyses of distribution of neurite
branch numbers did not show any signiﬁcant difference
between the control and miR-130a groups, indicating that
neurite numbers were not affected by miR-130a (Fig. S3B).
MiR-130a expression decreases dendritic complexity
Dendritic formation and maturation is critical for the formation
and maintenance of the nervous system. To study the effect
of miR-130a on dendrite formation, rat E18 primary cortical
neurons were cultured for 7 days and then transfected with
the control or miR-130a, and then ﬁxed at DIV18 for exam-
ining dendritic morphology. The dendrites were traced and
analyzed using NeuronJ (ImageJ) and NeuronStudio with
neuronal morphology quantiﬁed using Sholl analysis as
described previously (Kutzing et al., 2010; Langhammer
et al., 2010). Dendritic complexity was decreased in miR-
130a transfected neurons as compared with the control
neurons, including the number of branch points and terminal
points per neuron, as well as the number of intersections
(Fig. 3A–C). Further analyses revealed that miR-130a
decreased the number of secondary and tertiary branches,
but did not affect primary branches (Fig. 3D and 3E). The
lack of effect on primary branches by miR-130a is consistent
with what was observed with the number of neurites
(Fig. S3). In addition, the total length of dendrites was
decreased in miR-130a expressing neurons as compared
with the control group, although the average length of seg-
ments did not change (Fig. 3F and 3G). These data together
Table 1. Candidate target protein-coding genes for miR-130a







Axon guidance KEGG PATHWAY 9 129 0.0102891
Synaptic vesicle formation KEGG PATHWAY 5 63 0.0321619
Lissencephaly gene (LIS1) in neuronal
migration and development
PID 3 19 0.0403738




Hereditary spastic paraplegia (SPG) KEGG DISEASE 4 21 0.0058905
Autistic spectrum disorder FunDO 6 68 0.013854
Schizophrenia FunDO 10 172 0.0239614
Lissencephaly KEGG DISEASE 2 6 0.0218963
Non-syndromic X-linked mental
retardation
KEGG DISEASE 3 22 0.0368521
Congenital disorders of development KEGG DISEASE 13 244 0.0426269
Isolated orofacial clefts KEGG DISEASE 2 14 0.0803631
Spinocerebellar ataxias FunDO 2 12 0.0520478
Target genes for miR-130a were predicted using TargetScan, miRanda and PicTar. The intersection of the results from all three tools was
accepted as the potential targets. A total of 475 potential target genes were identiﬁed by the bioinformatics analyses (see MATERIALS AND
METHODS). Shown in the table are the pathways most enriched with protein-coding genes predicted to be targets of miR-130a (“MiR-130a
target genes” column) and corresponding raw P-values. The “Gene set size” is determined based on the protein coding genes in the genome
that have been annotated with the speciﬁc pathways by the respective database..
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show that miR-130a expression reduces dendritic complex-
ity, in particular, inhibits the formation of the secondary and
tertiary branches.
MECP2 is a target of miR-130a
To investigate mechanism of miR-130a function, we sought
to identify candidate target genes for miR-130a. Among the
potential target gene pathways predicted by our bioinfor-
matics analyses (Table 1), we decided to ﬁrst examine
candidate genes involved in neurodevelopment and asso-
ciated with neurodevelopmental diseases. MECP2 is one of
these predicted target genes for miR-130a. The human
MECP2 gene has a long conserved 3′UTR (∼8 kb) with
containing 4 predicted miR-130a binding sites. The most
upstream miR-130a binding site located ∼240 nucleotide
downstream of the stop codon is highly conserved, from
human to rodents (Fig. 4A). To validate that MECP2 is a
target gene of miR-130a, a dual luciferase reporter assay in
HEK293 cells was performed. A luciferase reporter plasmid
was constructed containing a 415-bp fragment of the 3′UTR
of the human MECP2 gene including the most highly con-
served miR-130a binding site (the most upstream binding
site in the 3′UTR; Fig. 4A). When co-transfected with miR-
130a, luciferase activity of the MECP2 3′UTR reporter was
signiﬁcantly reduced, whereas mutating the predicted miR-
130a binding site in the MECP2 reporter (3′UTRmt) reversed
the miR-130a inhibition, indicating that the 3′UTR of the
human MECP2 gene is responsive to miR-130a expression
(Fig. 4B). The mRNA and protein levels of MeCP2 were
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Figure 2. MiR-130a decreases the length of neurites in cultured primary cortical neurons. (A) Cortical neurons isolated from
E18 rat embryos were electroporated with the vector control (Ctr; upper panels A1–A4) or the miR-130a expression plasmid (lower
panels a1–a4) and cultured for 3 days. Representative images of neurons are shown from either control or miR-130a groups to
illustrate the range of neurite outgrowth. Scale bar: 25 μm. (B) Cortical neurons from E18 embryos were electroporated with the
scrambled RNA control (Scr; upper panels B1–B4) or the miR-130a inhibitor (MiR-130a-inh; lower panels b1–b4) and cultured for 3
days. Representative images of neurons are shown for the corresponding groups to illustrate the range of neurite outgrowth. Scale
bar: 25 μm. (C) Quantiﬁcation of the average lengths of the longest neurites (mean values ± SEM) in experiments shown in panels
(A) and (B). At least 100 neurons in each group were randomly selected and scored in each experiment. ***, P < 0.001, Mann-
Whitney test. Data represent three independent experiments.
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examined following transfection of pri-miR-130a or miR-130a
inhibitor. Western blotting of transfected rat cortical neurons
showed expression of miR-130a decreased MeCP2 protein
expression to ∼40% of that in the control group, whereas the
expression of the miR-130a inhibitor increased the MeCP2
protein level to ∼3 fold of that in the scramble control group
(Fig. 4C and 4E). RT-PCR assays showed that expression of
neither miR-130a nor miR-130a inhibitor altered the mRNA
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Figure 3. MiR-130a decreases the complexity of dendrites. (A) Cortical neurons were cultured for 7 days and transfected with
control or miR-130a. Cells were ﬁxed at 18 DIV. Images were taken using Leica confocal SP8. Image of 40× microscopy were
demonstrated. Scale bar: 25 μm. (B) The number of branch points and terminal points per cell. (C) The Sholl analysis of dendritic
complexity as measured by number of intersections. (D) The Sholl analysis of dendritic complexity by branch order-primary,
secondary and tertiary branches. (E) The number of segments in total and by branch order. (F) Average length of segments per cell.
(G) The total length of branches per cell. **, P < 0.01; ***, P < 0.001, Mann-Whitney test. Fifteen neurons were scored in each group in
each experiment. The bar diagram represents mean values ± SEM. Data represent 3 independent experiments.
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levels of MeCP2 (Fig. 4D and 4F). Because miRNAs may
regulate protein expression by translational inhibition or
mRNA degradation or both mechanisms (Hausser and
Zavolan, 2014; Vidigal and Ventura, 2015; Wilczynska and
Bushell, 2015), these results suggest that miR-130a may
decrease the MeCP2 protein level by affecting translation
efﬁciency rather than degrading MeCP2 mRNA. Future
studies are necessary to elucidate the precise mechanisms
by which miR-130a regulates MeCP2 protein production.
Restoring MeCP2 expression rescues miR-130a-
mediated inhibition of neurite outgrowth
It was reported that MeCP2 promotes axon outgrowth in
mouse primary cortical neurons (Jugloff et al., 2005). The
phosphorylation of MeCP2 at Ser80 is necessary for MeCP2
chromatin binding ability and neurological function (Tao et al.,
2009). When the Ser80 wasmutated to alanine (MeCP2S80A),
the S80A-mutant MeCP2 protein cannot be phosphorylated,
acting as a loss-of function mutant. We co-transfected the
wild-type MeCP2 or MeCP2S80A together with miR-130a into
cortical neurons and examined if MeCP2 could rescue the
effect of miR-130a on the neurite outgrowth. The average
neurite length was measured as described above. Neurons
transfected with MeCP2 alone showed longer neurite length,
approximately 2 fold of that of control neurons, whereas
neurons transfectedwithMeCP2S80Amutant did not showany
changes in the average neurite length (Fig. 5A and 5B).
Expression of MeCP2 in miR-130a transfected neurons sig-
niﬁcantly increased neurite length, ∼30% longer than that of
neurons transfected with miR-130a alone. However, expres-
sion of the mutant form of MeCP2, MeCP2S80A, ablated this
rescue effect. Our data show that miR-130a negatively regu-
lates neurite length in part by down-regulating MeCP2.
MiR-130a decreases dendritic spine density and MeCP2
rescues the miR-130a-induced phenotype
Dendritic spines are membrane protrusions on dendrites and
play critical roles in the formation of synapses and neural
circuits (Ethell and Pasquale, 2005). We examined the effect
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Figure 4. The MECP2 gene is a target of miR-130a. (A) Alignment of the binding sites of miR-130a on MECP2 mRNA 3′UTR. The
seed regions of miR-130a binding sites are in italics. Luciferase reporter plasmids containing the human MECP2-3′UTR regions,
either the wild type UTR (MECP2-3′UTR) or the mutant UTR with the most highly conserved binding site for miR-130a mutated as
shown (MECP2-3′UTR mutant). (B) A dual luciferase reporter assay. Relative luciferase activity was measured in HEK293 cells at
48 h post-transfection. The wild-type MECP2-3′UTR is referred to as “3′UTR”, whereas the mutant described in panel (A) is indicated
as “3′UTRmt”. (C) The MeCP2 protein levels as detected by Western blotting. Rat E18 cortical neurons were electroporated with the
control vector, miR-130a, scramble RNA (Scr) or miR-130a inhibitor (miR-130a-inh). β-Tubulin was used as an internal control.
(D) The MeCP2 mRNA levels as assayed by RT-PCR with β-tubulin as an internal control. (E and F) Quantiﬁcation and statistical
analysis of data in (C) and (D). The bar diagram represents mean values ± SEM. Data represent three independent experiments.
*, P < 0.05; **, P < 0.01; ***, P < 0.001. Mann-Whitney test.
RESEARCH ARTICLE Yunjia Zhang et al.









experiments, rat E18 primary cortical neurons were cultured
for 21 days in vitro and then transfected using Lipofectamine
with the control or with miR-130a. Cells were then ﬁxed 3
days post-transfection. The density of dendritic spines on the
secondary and tertiary dendritic branches was determined.
Neurons transfected with miR-130a showed fewer dendritic
spines as compared with the control neurons (Fig. 6A, panel
a1 and a2). Both gain-of- and loss-of-function mutations of
the MECP2 gene lead to neurodevelopment disorders with
dendritic spine morphological abnormalities, suggesting the
proper level of functional MeCP2 is critical for neural devel-
opment (Jiang et al., 2013; Xu et al., 2014). Indeed, over-
expression of MeCP2 alone reduced dendritic spine density
(Fig. 6A, panel a5), consistent with previous data from hip-
pocampal slice cultures (Xu et al., 2014).
We then asked whether the phenotype of decreased spine
density by miR-130a was mediated by regulating MeCP2.
Neurons co-expressing miR-130a and MeCP2 showed a par-
tial rescue effect, with a higher density than neurons trans-
fected with either miR-130a or MeCP2 alone (Fig. 6A, panel
a3). This rescue effect was not observed when S80A mutant
MeCP2 was co-transfected with miR-130a (Fig. 6A, panel a4).
Taken together, our data suggest that miR-130a decreases
dendritic spine density in part by regulating MeCP2.
DISCUSSION
In this study we sought to determine the role of miR-130a in
neuronal development, and examined whether effects of
miR-130a were mediated by regulating MECP2 gene
expression. Consistent with previous studies carried out in
mice (Hoesel et al., 2010; Eda et al., 2011; Søe et al., 2011),
miR-130a is expressed in rat cortical neurons at the late
embryonic and early postnatal stages (Fig. 1). Bioinformatics
analyses suggest that miR-130a may be involved in neuro-
genesis and associated with neurodevelopmental disorders
such as schizophrenia, lissencephaly and autism (Table 1)
(Poluch and Juliano, 2015; Selemon and Zecevic, 2015;
Wang and Baraban, 2007; Wegiel et al., 2010). Neurogen-
esis is not only essential for the formation of the nervous
system during development, but also critical for the mainte-
nance and neural repair in the adult brain (Feliciano et al.,
2015; Zhao et al., 2008). Defects in neurogenesis are
associated with a large number of neurological disorders,
including neurodevelopmental diseases and neurodegener-
ative disorders such as Alzheimer’s Disease and Parkin-
son’s Disease (Merson and Bourne, 2014; Schoenfeld and
Cameron, 2015; Winner and Winkler, 2015).
Our bioinformatics analyses suggest that miR-130a may
be involved in many pathways critical for neurodevelopment
and associated with pathogenesis of neurodevelopmental
diseases (Table 1). Using primary neuronal cultures, we
provided experimental evidence that miR-130a plays a role
in regulating both neurite outgrowth and dendritic formation.
The outgrowth of neurites, which will differentiate into axons
and dendrites, is an important event in neural development
(Takano et al., 2015; Lefebvre, Sanes, Kay 2015). MiR-130a
expression reduces neurite outgrowth, whereas miR-130a
inhibitor increases neurite outgrowth (Fig. 2). Expression of
miR-130a also reduces dendritic complexity without affecting
the number of primary dendritic branches (Fig. 3). Finally,
miR-130a reduces the density of dendritic spines (Fig. 6).
Overall, these results suggest that miR-130a may play a
complex role in regulating neurogenesis and neuronal dif-
ferentiation. The expression of miR-130a was reported to be
decreased in the cerebral cortex of mouse brain but
increased in hippocampus from birth to adulthood (Eda et al.,
2011). This dynamic expression pattern of miR-130a sug-
gests that the function of miR-130a in the nervous system
may be different depending on the speciﬁc regions and


































Figure 5. Expression of miR-130a decreases the length of
neurites, a phenotype partially rescued by wild type MeCP2
but not by a loss-of-function MeCP2 mutant. (A) Rat E18
cortical neurons were electroporated with the vector control,
miR-130a, MeCP2, MeCP2S80A or miR-130a together with
MeCP2 or MeCP2S80A and cultured for 3 days before imaging.
Scale bar: 25 μm. (B) The average length of the longest neurites
in (A) were measured and statistically analyzed from three
independent experiments (mean values ± SEM; at least 100
neurons in each group were scored in each experiment). **, P <
0.01; ***, P < 0.001. Mann-Whitney test.
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observed that the expression of a number of miRNAs was
affected in MeCP2-deﬁcient mice, including the down-regu-
lation of miR-130a (Urdinguio et al., 2010). Together with our
data, these results suggest that miR-130a together with
MeCP2 may participate in a feedback regulatory loop that
maintain the appropriate levels of both miR-130a and
MeCP2 to ensure their proper function of neural develop-
ment in a spatially and temporally regulated manner. It is
obvious that further studies are necessary for elucidating the
role of miR-130a in neurodevelopment.
Our data support that miR-130a inhibits neurite outgrowth,
at least in part, by regulatingMECP2, a predicted target gene
by threebioinformatics tools.MiR-130aexpressiondecreased
the protein level of MeCP2 but did not affect its mRNA level
(Fig. 4). This can be explained by the possible activity of miR-
130a in regulating translation efﬁciency rather than mRNA
stability, a mechanism that has been described for a subset of
miRNAs (Baek et al., 2008). The humanMECP2 gene has at
least 4 transcripts of different lengths, among which the 10 kb
mRNA contains the longest 3′UTR (∼8 kb). This transcript is
predominantly expressed in the brain, whereas the short
transcripts are mainly expressed in the lung and liver (Pelka
et al., 2005). Only the longest 3′UTR contains multiple miR-
130a binding sites in different species. In addition, the 3′UTR
of MECP2 is highly conserved in both sequence and RNA
secondary structure (Coy et al., 1999). These all suggest that
miR-130a may regulate MeCP2 in a conserved manner and
the regulation may be relatively speciﬁc to the nervous sys-
tem. Variants in the MECP2 3′UTR were found among
patients affected by autismandRett syndrome, although none
of the variants is predicted to be pathogenic to Rett syndrome
(Santos et al., 2008; Shibayama et al., 2004). However,
MeCP2 mRNA levels in four autism patients carrying con-
served 3′UTR alterations were lower (Coutinho et al., 2007).
These ﬁndings suggest that mutations in the 3′UTR might
impact the expression ofMeCP2 (McGowanandPang, 2015).
It has been reported previously that DNA methylation and
histone modiﬁcation are important to neurite outgrowth in
PC12 cells (Futamura et al., 1995; Persengiev and Kilpatrick,
1996). MeCP2 is a methylated DNA binding protein regulat-
ing gene transcription, playing important roles in histone
deacetylation and chromatin remodeling by recruiting histone
deacetylase (Chahrour et al., 2008; Jones et al., 1998; Nan
et al., 1998). MeCP2 was reported to promote axon out-
growth in mouse cortical neurons, and the suppression of
MeCP2 in PC12 cells inhibited the neurite extension (Cusack
et al., 2004; Jugloff et al., 2005). MeCP2S80A could not be
phosphorylated and lacked the chromatin binding ability (Tao
et al., 2009). In addition, it was found that S80-phosphory-
lated MeCP2 could suppress nuclear miRNA processing by
binding Drosha, the initial processing complex for generating
pre-miRNAs, and regulate Drosha function in an activity-de-
pendent manner (Cheng et al., 2014). In our study, the wild
type MeCP2 promoted neurite outgrowth and effectively
rescued the phenotype induced by miR-130a, whereas
MeCP2S80A lost this activity (Fig. 5). Because MeCP2 also
regulates microRNA biogenesis, including that of miR-130a
(Urdinguio et al., 2010), it might be difﬁcult to interpret com-
plex results if the rescue experiments were performed in
MeCP2-null background. These results suggest that miR-
130a inhibits neurite outgrowth by targeting MeCP2, and that
MeCP2 may affect neurite outgrowth via its activity in regu-
lating chromatin structure and/or modulating miRNA pro-
cessing. Much more work is necessary to further understand
the underlying mechanisms, especially the reciprocal rela-
tionship between MeCP2 and miR-130a.
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Figure 6. Expression of miR-130a decreased the density of
dendritic spines, a phenotype that can be rescued by
functional MeCP2 but not by MeCP2 mutant. (A) Rat E18
cortical neurons were cultured for 21 days and then transfected
with vector control, miR-130a, MeCP2, MeCP2S80A or miR-130a
mixed with MeCP2 or MeCP2S80A. Upper panels (A1–A6): image
of 20× microscopy demonstrated the healthy morphology of
neurons. The boxed areas by dotted lines in the top panels are
enlarged and shown in lower panels and used for quantiﬁcation of
the secondary and tertiary dendrites. Scale bar: 75 μm. Lower
panels (a1–a6): high magniﬁcations of image (100× lens; zoom
4.0×) demonstrated the morphology of dendritic spines. Scale
bar: 2.5 μm. (B) The average density of dendritic spines. Spines
on the secondary and tertiary dendrites were measured. The bar
diagram represents mean values ± SEM. Data represent three
independent experiments (Ten neurons were scored in each
experiment). **, P < 0.01; ***, P < 0.001, Mann-Whitney test.
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Reduced dendritic spine density is a common feature in
individuals with Rett syndrome (Phillips and Pozzo-Miller,
2015; Xu et al., 2014), knockdown of the endogenous
MeCP2 also reduced dendritic spine density (Chapleau
et al., 2009). Consistent with this, expression of MeCP2
rescued the decreased spine density caused by miR-130a. It
has been reported that dendritic spine density in terminal
dendritic branches of young transgenic mice expressing
MeCP2 (a MECP2 duplication syndrome mouse model) was
initially higher than the control group and then decreased
after postnatal week 12 (Jiang et al., 2013). The dendrite
outgrowth phenotype in the MeCP2 overexpressing mice
during the early stage (See Fig. 1 of Jiang et al., 2013) is
consistent with our observation. On the other hand, it has
also been reported that expression of MeCP2 inhibited
dendritic spine development in rat hippocampal slice cul-
tures (Cheng et al., 2014). Data from different studies sug-
gest that both MeCP2 overexpression and MeCP2 loss of
function result in complex phenotypes in dendritic develop-
ment (Na et al., 2013; Zhou et al., 2006; Jiang et al., 2013;
Cheng et al., 2014). Therefore, the observation in our neu-
ronal culture system that MeCP2 increased dendritic spine
density in miR-130a expressing neurons may reﬂect a deli-
cate balance and dynamic changes in the combinatorial
effects of MeCP2 and microRNAs during dendritic
development.
Neurons require proper homeostasis of MeCP2 to func-
tion normally (Lombardi et al., 2015). Loss of function of
MeCP2 leads to severe neurodevelopmental diseases such
as Rett syndrome, autism and schizophrenia; whereas the
gain of function of MeCP2 may cause MECP2 duplication
syndrome (Lombardi et al., 2015; Van Esch, 2011). Pheno-
types of Rett syndrome and MECP2 duplication syndrome in
mouse models can be reversed if MeCP2 level is properly
restored (Robinson et al., 2012; Sztainberg et al., 2015).
Taken together, our data support that miR-130a exhibits an
inhibitory role on neurite outgrowth, dendritic branching and
dendritic spine maturation, partially by targeting MeCP2.
Seminal reviews on miRNAs have discussed about miRNAs
as multi-facet regulators acting beyond simple repression of
gene expression: buffering noise in the expression of their
targets or setting a threshold-linear response (Bartel, 2009;
Hausser and Zavolan, 2014). In this way, miR-130a could
serve to buffer changes in MeCP2 protein expression and
may help maintain MeCP2 at an appropriate level, which is
essential for its function. Future studies are necessary to
elucidate the complex mechanisms controlling all these
events.
MATERIALS AND METHODS
Prediction of target genes for miR-130a by bioinformatics analyses
Target genes for miR-130a were predicted using TargetScan, miR-
anda and PicTar. The intersection of the results from all three tools
was accepted as the potential targets. The Entrez Gene IDs of
potential targets were downloaded from Ensembl and entered into
KOBAS2.0 (with default setting) for annotation of gene pathways,
disease associated genes and GeneOntology (GO) terms. The
result of annotation was then used to identify statistically signiﬁcantly
enriched pathways, diseases and GO terms using protein-coding
genes from the whole human genome set (20,192 genes) as
background.
Cell culture and transfection
Embryonic day 18 (E18) rat cortical neurons were cultured and
transfected following published protocols (Gao et al., 2010; Guo
et al., 2011). Brieﬂy, following electroporation (Amaxa Nucleo-
fector II), neurons were seeded onto poly-D-lysine coated cov-
erslips in 12-well plates. In the experiments for analyses
of dendrite morphology and spine density, Lipofectamine2000
was used for transfecting neurons at 7 days and 21 days in vitro
(DIV).
Plasmids and RNA inhibitors
MeCP2 and MeCP2S80A plasmids were as described previously
(Cheng et al., 2014). MiR-130a plasmid was generated using pCDH-
CMV-MCS-EF1-copGFP (CD511B-1, System Biosciences) accord-
ing to the manufacturer’s instructions. MiR-130a genomic sequence
was ampliﬁed with the following primers: forward, 5′-TGCTCTA-
GAGGTCATCTGAGAGTGTTGCCT-3′; reverse, 5′-CCGGGATCCT-
GACCCTCAGTTTTTCATCCA-3′. The miR-130a inhibitor was a
methylation-modiﬁed RNA oligonucleotide complementary to miR-
130a (GenePharma).
Luciferase reporter assay
Plasmids expressing wild-type or mutant human MECP2 3′UTR
reporter genes containing a 415-bp fragment including the most
conserved miR-130a binding site (shown as the “240 site” in Fig. 4A)
were constructed using psiCHECK2 vector (Promega). The PCR
ampliﬁcation primers were as follows, wild-type MECP2-3′UTR pri-
mers: forward primer, 5′-CCGCTCGAGCGGAGCGGATTGCAAA
GC-3′; and reverse primer, 5′-ATTTGCGGCCGCTGTAGACGG
GGCACTGATGG-3′. The mutant forward primer is designed across
the ﬁrst miR-130a binding site, introducing a mutation that scrambles
the entire seed region (underlined portion, see Fig. 4A): MECP2-3′
UTR mutant primers: forward, 5′-GGCCAGAAGTAGCTAACGTGAT
TTCTA AACTAGGCTC-3′; and reverse, 5′-GCCTAGTTTAGA
AATCACGTTAGCTACTTCTGGCCC-3′. The positive control was
the same vector inserted with the complementary sequence of miR-
130a. Luciferase assay was performed using Dual-Luciferase®
Reporter Assay System (Promega). MiR-130a and MECP2 3′UTR
were co-transfected to HEK293 cells at the ratio of 36.5:1. 48 h
following transfection, cells were lysed with the activity of Renilla
luciferase measured according to the manufacturer’s instructions.
RNA extraction and RT-PCR
Total RNA was extracted using TriZol reagent (Invitrogen). Genomic
DNA was removed with RNase-free DNase (NEB). Total cDNA was
reverse-transcribed using SuperScript™ III Reverse Transcriptase
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(Invitrogen). PCR primers of MeCP2 are: forward, 5′-AGAGGAA
GTCTGGTCGCTCT-3′, reverse, 5′-CCAGGCTTTCTACCCCGTTT-3′.
Primary miR-130a: forward, 5′-AGGATGAGAGGAAGGCTGTG-3′,
reverse, 5′-AGAAAACAGTGACGCTGAGG-3′; GAPDH: forward,
5′-CCCCCAATGTATCCGTTGTG-3′, reverse, 5′-TAGCCCAGGATG
CCCTTTAGT-3′; U6: forward, 5′-CTCGCTTCGGCAGCACA-3′,
reverse, 5′-AACGCTTCACGAATTTGCGT-3′.
RT-PCR detection of mature miR-130a was performed using poly
(T) adaptor-PCR as described previously (Shi et al., 2012). Poly
(T) adaptor: 5′-AAGCAGTGGTATCAACGCAGAGTGC(T)30VN-3′;
poly(T) adaptor reverse primer: 5′-CTCACACGACTCACGACAGG
GCAAGCAGTGGTATCAACGCAGAGTG-3′; miR-130a speciﬁc for-
ward primer: 5′-TGCGGCAGTGCAATGTTAAAAGGGCAT-3′.
TUNEL assay
E18 rat cortical neurons were dissociated and electroporated with
control vector or miR-130a plasmid. Cells were cultured for 3 days.
Terminal deoxyribonucleotidyl transferase (TDT)-mediated dUTP-
digoxigenin nick end labeling (TUNEL) was performed using In Situ
Cell Death Detection Kit (Roche) as described in (Zhu et al., 2014).
Western blotting analysis and Immunostaining
MeCP2 antibody was prepared as previously described (Hu et al.,
2006). Tubulin antibody and secondary antibodies were from Pro-
teinTech Group. Protein lysates were prepared from rat brain tissues
or cultured cells for Western blotting analyses using corresponding
antibodies following our previously published protocols with a
chemiluminescence HRP detection kit (Millipore) (Guo et al., 2011;
Deng et al., 2015).
For immunostaining, cellswerewashed in pre-warmedphosphate-
buffered saline (PBS) and ﬁxed in 4% paraformaldehyde (PFA). The
ﬁxed cells were permeabilized and blocked with 10% normal goat
serum (NGS) plus 0.3% Triton X-100 in PBS, incubated with primary
antibody: rabbit anti-beta tubulin antibody (1:70) (PTG). After washing
5 times, the cells were incubated with secondary antibody conjugated
to Alexa Fluor® 594 (1:500) (Invitrogen) and stained with 4’,6’-di-
amidino-2-phenylindole (DAPI; 1 μg/mL). The coverslips were
mounted with PermaFluor aqueous mounting medium (Thermo).
Morphological analyses of axons and dendrites
The images for neurite outgrowth were taken using an inverted ﬂu-
orescence microscope (Nikon) following a previously published
protocols (Gao et al., 2010). The images for dendrite morphology
and dendritic spines were taken using a confocal microscope (Leica
SP8); image analyses were carried out following the published
protocols (Langhammer et al., 2010; Srivastava et al., 2011).
Statistical analyses
The data was normalized to the control group. Statistical analyses
were performed using Mann-Whitney test, between individual
groups and two-way ANOVA for comparing distributions. *, P < 0.05;
**, P < 0.01; ***, P < 0.001. The bar diagram represents mean
values ± SEM.
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